drug protocol number
M23-784
drug sponsor
AbbVie
drug study
Risankizumab
drug trial site
Aseer Central Hospital (Abha), International Medical Center (Jeddah), King Khalid University Hospital (Riyadh)
drug status
Ongoing
drug phase